Your browser doesn't support javascript.
loading
CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216.
Gress, Verena; Roussy, Mathieu; Boulianne, Luc; Bilodeau, Mélanie; Cardin, Sophie; El-Hachem, Nehme; Lisi, Véronique; Khakipoor, Banafsheh; Rouette, Alexandre; Farah, Azer; Théret, Louis; Aubert, Léo; Fatima, Furat; Audemard, Éric; Thibault, Pierre; Bonneil, Éric; Chagraoui, Jalila; Laramée, Louise; Gendron, Patrick; Jouan, Loubna; Jammali, Safa; Paré, Bastien; Simpson, Shawn M; Tran, Thai Hoa; Duval, Michel; Teira, Pierre; Bittencourt, Henrique; Santiago, Raoul; Barabé, Frédéric; Sauvageau, Guy; Smith, Martin A; Hébert, Josée; Roux, Philippe P; Gruber, Tanja A; Lavallée, Vincent-Philippe; Wilhelm, Brian T; Cellot, Sonia.
Afiliação
  • Gress V; Pediatric Hematology-Oncology Division, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire Sainte-Justine Research Center, Montréal, QC, Canada.
  • Roussy M; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.
  • Boulianne L; Pediatric Hematology-Oncology Division, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire Sainte-Justine Research Center, Montréal, QC, Canada.
  • Bilodeau M; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.
  • Cardin S; Pediatric Hematology-Oncology Division, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire Sainte-Justine Research Center, Montréal, QC, Canada.
  • El-Hachem N; Department of Pathology, McGill University, Montréal, QC, Canada.
  • Lisi V; Pediatric Hematology-Oncology Division, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire Sainte-Justine Research Center, Montréal, QC, Canada.
  • Khakipoor B; Pediatric Hematology-Oncology Division, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire Sainte-Justine Research Center, Montréal, QC, Canada.
  • Rouette A; Pediatric Hematology-Oncology Division, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire Sainte-Justine Research Center, Montréal, QC, Canada.
  • Farah A; Pediatric Hematology-Oncology Division, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire Sainte-Justine Research Center, Montréal, QC, Canada.
  • Théret L; Pediatric Hematology-Oncology Division, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire Sainte-Justine Research Center, Montréal, QC, Canada.
  • Aubert L; Molecular Diagnostic Laboratory, Centre Hospitalier Universitaire Sainte-Justine, Montréal, QC, Canada.
  • Fatima F; Pediatric Hematology-Oncology Division, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire Sainte-Justine Research Center, Montréal, QC, Canada.
  • Audemard É; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.
  • Thibault P; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.
  • Bonneil É; Pediatric Hematology-Oncology Division, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire Sainte-Justine Research Center, Montréal, QC, Canada.
  • Chagraoui J; Department of Pathology, McGill University, Montréal, QC, Canada.
  • Laramée L; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.
  • Gendron P; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.
  • Jouan L; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.
  • Jammali S; Molecular Genetics of Stem Cells Laboratory, Institute for Research in Immunology and Cancer, Montréal, Québec, Canada.
  • Paré B; Pediatric Hematology-Oncology Division, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire Sainte-Justine Research Center, Montréal, QC, Canada.
  • Simpson SM; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.
  • Tran TH; Molecular Diagnostic Laboratory, Centre Hospitalier Universitaire Sainte-Justine, Montréal, QC, Canada.
  • Duval M; Pediatric Hematology-Oncology Division, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire Sainte-Justine Research Center, Montréal, QC, Canada.
  • Teira P; Pediatric Hematology-Oncology Division, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire Sainte-Justine Research Center, Montréal, QC, Canada.
  • Bittencourt H; Pediatric Hematology-Oncology Division, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire Sainte-Justine Research Center, Montréal, QC, Canada.
  • Santiago R; Pediatric Hematology-Oncology Division, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire Sainte-Justine Research Center, Montréal, QC, Canada.
  • Barabé F; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.
  • Sauvageau G; Pediatric Hematology-Oncology Division, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire Sainte-Justine Research Center, Montréal, QC, Canada.
  • Smith MA; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.
  • Hébert J; Pediatric Hematology-Oncology Division, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire Sainte-Justine Research Center, Montréal, QC, Canada.
  • Roux PP; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.
  • Gruber TA; Pediatric Hematology-Oncology Division, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire Sainte-Justine Research Center, Montréal, QC, Canada.
  • Lavallée VP; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.
  • Wilhelm BT; Division of Hematology-Oncology, Centre Hospitalier Universitaire de Québec-Université Laval, Québec City, QC, Canada.
  • Cellot S; Centre de recherche du Centre Hospitalier Universitaire de Québec-Université Laval, Québec City, QC, Canada.
Blood Adv ; 8(1): 112-129, 2024 01 09.
Article em En | MEDLINE | ID: mdl-37729615

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Megacarioblástica Aguda / Antineoplásicos Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Megacarioblástica Aguda / Antineoplásicos Idioma: En Ano de publicação: 2024 Tipo de documento: Article